AdvaMed Statement on HHS Rescission of Policies on Laboratory Developed Tests During COVID and Beyond
WASHINGTON, D.C. – AdvaMed President and CEO Scott Whitaker released the following statement:
COVID-19
COVID-19: The Role Of In Vitro Diagnostic Testing – Backgrounder
Read background information on how AdvaMedDx’s members produce IVD tests to detect COVID-19.
Op-Ed: AdvaMed’s Whitaker Details New National Testing Supply Registry
Unequal access to medical technologies and, more broadly, health care services continues to persist – often disproportionately impacting the lives of racial and ethnic minorities.
COVID Test Shipments Top One Million Per Day
AdvaMed announced that shipments of COVID-19 molecular diagnostic tests reached one million per day for the week ending July 24, based on the latest data from the association’s National Testing Registry.
26 Health Care Groups Sign On To “Return To Procedures” Guidance
WASHINGTON, D.C. – The Advanced Medical Technology Association (AdvaMed), the Association of periOperative Registered Nurses (AORN), and the American Hospital Association (AHA) today announced 26 additional health care professional societies and…
AdvaMed Joins AORN, AHA in Issuing “Re-entry Guidance for Health Care Facilities and Medical Device Representatives”
AdvaMed, the Association of periOperative Registered Nurses (AORN), and the American Hospital Association (AHA) today released “Re-entry Guidance for Health Care Facilities and Medical Device Representatives.”
Medtech Companies Are Manufacturing Critical COVID-19 Tests
Doctors, nurses and health care providers fighting on the front lines against the coronavirus are modern-day heroes. Every day they selflessly risk their own health to provide essential care to…
Chinese Government’s Evaluation Process Of Manufacturers’ Standards And Qualifications For Relevant Epidemic Prevention Products
View a flow chart of the evaluation process.
China’s Process For Allowing The Export Of COVID-19 Products Without NMPA Approval
The Chinese government announced a process to export particular devices without NMPA approval.